NLRP11 disrupts MAVS signalosome to inhibit type I interferon signaling and virus-induced apoptosis

EMBO Rep. 2017 Dec;18(12):2160-2171. doi: 10.15252/embr.201744480. Epub 2017 Nov 2.

Abstract

MAVS signalosome plays an important role in RIG-I-like receptor (RLR)-induced antiviral signaling. Upon the recognition of viral RNAs, RLRs activate MAVS, which further recruits TRAF6 and other signaling proteins to initiate type I interferon (IFN) activation. MAVS signalosome also regulates virus-induced apoptosis to limit viral replication. However, the mechanisms that control the activity of MAVS signalosome are still poorly defined. Here, we report NLRP11, a Nod-like receptor, is induced by type I IFN and translocates to mitochondria to interact with MAVS upon viral infection. Using MAVS as a platform, NLRP11 degrades TRAF6 to attenuate the production of type I IFNs as well as virus-induced apoptosis. Our findings reveal the regulatory role of NLRP11 in antiviral immunity by disrupting MAVS signalosome.

Keywords: MAVS; NLRP11; TRAF6; apoptosis; type I IFNs.

MeSH terms

  • Adaptor Proteins, Signal Transducing / metabolism*
  • Apoptosis*
  • Gene Expression Regulation
  • Host-Pathogen Interactions / genetics
  • Humans
  • Immunity, Innate
  • Interferon Type I / antagonists & inhibitors*
  • Interferon Type I / metabolism*
  • Intracellular Signaling Peptides and Proteins / genetics
  • Intracellular Signaling Peptides and Proteins / metabolism
  • Mitochondria / metabolism
  • NLR Proteins / genetics*
  • NLR Proteins / metabolism
  • Sendai virus / physiology
  • Signal Transduction
  • THP-1 Cells
  • TNF Receptor-Associated Factor 6 / metabolism
  • Virus Replication

Substances

  • Adaptor Proteins, Signal Transducing
  • Interferon Type I
  • Intracellular Signaling Peptides and Proteins
  • MAVS protein, human
  • NLR Proteins
  • TNF Receptor-Associated Factor 6
  • Tifab protein, human